News

Research – Trovagene (TROV) – Funding for trial

Health
0 min read

Friday, February 1, 2019

Trovagene Inc. (TROV)

PoC Capital Agreement to Fund Colorectal Cancer Trial

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Listen to the Analyst

RATING: OUTPERFORM

GET MORE

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy